Tonix Pharmaceuticals (TNXP) Misses Q4 EPS by 2c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q4 EPS of ($0.83), $0.02 worse than the analyst estimate of ($0.81).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• ZWTC 2026 Enters Squad Stage as Zoomex Opens Registration for Competition With Up to 2.5 Million USDT in Prizes
• Raymond James Reiterates Underperform Rating on Lennar (LEN)